Meningioma Mommas makes it mark on home turf by awarding a $29,443 grant to University of Colorado researchers, Dr. Michael Graner, Dr. Kevin Lillehei, Dr. Debra Damek and Dr. Phil Tatman for their project, “Determining the Therapeautic Potential of Targeting DNA Methylation in Meningiomas, and the Establishment of Aggressive and Recurrent Cell Lines.” This proposal will…
Meningioma Mommas celebrates its 15th year of providing a 24/7 support lifeline and only funding meningioma specific research. We are thrilled to support the continued work of Harvard researchers, Dr. Robert Martuza and Dr. Hiroaki Wakimoto, with a $24,150 grant to extend their project, “Anti-angiogenic Oncolytic Virus Therapy for Meningioma.” They have identified promising new…
Meningioma Mommas has chosen Stanford University as its latest grant recipient. Meningioma Mommas awarded a $10,000 award to neurosurgeon and researcher, Dr. Melanie Hayden Gephart for her project, Gadolinium-based Contrast and Meningioma Monitoring. Gadolinium-based contrast agents (GBCA) are a class of intravenous drugs commonly used to enhance magnetic resonance imaging (MRI) studies. GBCA aid in the…
Meningioma Mommas only funds meningioma specific research and is proud to kick off 2017 by fully funding Harvard University and Massachusetts General Hospital researchers, Dr. Robert Martuza and Dr. Hiroaki Wakimoto, with a $25,048 grant to launch their project, “Anti-angiogenic Oncolytic Virus Therapy for Meningioma.” This is exciting as there is no effective modality for…
Dr. Nader Sanai, an Associate Professor of Neurological Surgery at the Barrow Neurological Institute in Phoenix, Arizona, has received a $15,000 grant to fund his latest research project, “A Phase 0/II Study of LEE011 in Recurrent Atypical and Malignant Meningioma Patients.” This proposal represents the first Phase 0 atypical and malignant meningioma trial in history. Dr. Sanai and…
Meningioma Mommas funded Dr. Garni Barkhoudarian and Dr. Daniel Kelly (John Wayne Cancer Institute at Saint John’s Health Center) with a $15,000 grant in December, 2013. Dr. Barkhoudarian writes, “This pilot study which resulted in the identification of numerous potential biomarkers between grade 2 and grade 3 meningiomas. Though this was primarily a feasibility study,…
Meningioma Mommas is thrilled to announce that Dr. Albert Kim has been awarded $20,952 to fully fund his latest research project, “Mechanisms of Radiation Resistance in Brain Meningiomas”. Dr. Kim, an academic neurosurgeon at Washington University in St. Louis studies meningiomas clinically and has been focusing on the effects of radiation therapy in aggressive grade II…
Dr. Long-Sheng Chang’s research is officially underway. Meningioma Mommas donated $10,000 to fund his project, “Evaluation of Novel Targeted Therapies for Both NF2-Associated and Sporadic Meningiomas.” The ultimate goal for Dr. Chang and his team at Ohio State University is to develop a medical therapy that effectively eradicates both NF2-associated and sporadic meningiomas. Meningioma Mommas…
“From the bottom of my heart, I sincerely thank Meningioma Mommas for supporting our research. In a time when research funding is so competitive, any penny counts! “Fearless” is the spirit that I have learned from patients with meningiomas like you. Despite how many tumors and surgeries you have and how life-altering the effects of these…